Curcumin is a natural compound that exhibits a wide range of beneficial effects, among them the anti-tumor activity. Recently it was shown that curcumin may be efficient against drug resistant tumor cells. The goal of our investigation was to examine if human laryngeal carcinoma cells resistant to carboplatin display sensitivity to curcumin, as compared to parental cells, and if this sensitivity is altered, to determine the molecular mechanisms that are responsible for it. We found that carboplatin resistant 7T cells were also cross resistant to curcumin. After the treatment with equimolar concentration of curcumin, 7T cells exhibited lower intracellular accumulation of curcumin which coincided with reduced formation of reactive oxygen species (ROS), diminished lipid and DNA damage followed by reduced induction of apoptosis and expression of heat shock protein 70 (Hsp70), as compared to parental HEp-2 cells. However, after the treatment with equitoxic concentration of curcumin, intracellular accumulation and all the explored downstream effects were similar in both cell lines suggesting that resistance of 7T cells to curcumin was based on its reduced intracellular accumulation. Since curcumin accumulates mostly in the membranes, we explored the fatty acid composition of both cell lines, but we did not find any difference between them.
Introduction
Curcumin (diferuloylmethane) is a yellow pigment derived from the rhizome of the plant Curcuma longa. The powdered rhizome of this plant, called turmeric, has been used in traditional Chinese and Hindu medicine for centuries in the treatment of different diseases (Chattopadhyay et al., 2004) . Although curcumin has shown a wide range of beneficial pharmacological effects, its anticancer properties have attracted a great interest. It has been shown that curcumin can induce the death of cancer cells and inhibit the formation of tumors in animal models of carcinogenesis (Kunnumakkara et al., 2008; Lopez-Lazaro, 2008; Teiten et al., 2010) . Since curcumin influences multiple components of intracellular signaling pathways and molecular targets involved in the development and progression of cancer (Lopez-Lazaro, 2008; Teiten et al., 2010) , it is a promising drug for the treatment of cancer as a multifactorial disease. The ongoing clinical trials should determine the possible beneficial effect of curcumin in cancer treatment, when given alone or in combination with conventional anticancer drugs (Teiten et al., 2010) .
There are numerous reports about the production of reactive oxygen species (ROS) during curcumin-induced apoptosis in different tumor cell lines (Atsumi et al., 2005; Chen et al., 2010; Fujisawa S, 2004; Hail, 2008; Kang et al., 2005) . These free radicals can cause serious damage to lipids, proteins, and DNA (Halliwell and Gutteridge, 1999) and they have been suggested as some of the initiators in apoptotic signaling (Carmody and Cotter, 2001; Circu and Aw, 2010) . Unfortunately, tumor cells can often evade apoptosis through many different mechanisms. Overexpression of some antiapoptotic proteins like Bcl-2, Bcl-XL and Smac protected cancer cells from curcumin treatment (Karunagaran et al., 2005) , while some curcumin resistant cell lines showed higher production of Hsp70 (Khar et al., 2001; Rashmi et al., 2003; Rashmi et al., 2004) .
Resistance of tumor cells to chemotherapy is the major obstacle that limits the effectiveness of cancer treatment. Therefore, novel strategies based on new compounds that could be efficient against drug resistant tumor cells would be a promising way to increase the effectiveness of cancer treatment. Literature data suggest that curcumin exerts the same anticancer effects in several drug resistant cell lines as in their sensitive parental counterparts.
This was shown for multidrug resistant myeloid leukemia cells (Lu et al., 2012) , cisplatin resistant ovarian cancer cells (Weir et al., 2007) , multiple myeloma cells resistant to 4 4 dexamethasone, doxorubicin and melphalan (Sung et al., 2009) , as well as hormone independent, multidrug resistant breast cancer cells (Labbozzetta et al., 2009 ).
Drug resistance is a general problem in cancer treatment. Since curcumin has been shown to be very efficient as anticancer agent in some chemoresistant cell lines, the knowledge about the mechanisms involved in modified sensitivity of drug resistant cells to this natural compound could be important in future attempts of using curcumin as antitumor agent in clinical applications, especially in treatment of drug resistant cancers. The goal of our investigation was to examine if human laryngeal carcinoma cells resistant to carboplatin display sensitivity to curcumin, as compared to parental cells, and if this sensitivity is altered, to determine the molecular mechanisms that are responsible for it.
Materials and methods

Cell culture and treatment with curcumin
Human laryngeal carcinoma HEp-2 cells were obtained from cell culture bank (Gibco, Grand Island, NY). Development of their subline resistant to carboplatin has been published previously (Osmak et al., 1995) . These cells were propagated for 26 passages without reversion in sensitivity to carboplatin and are now called 7T. HEp-2 and 7T cells were grown at 37ºC with 5% CO 2 as a monolayer culture in Dulbecco's modified Eagle's medium, DMEM (Gibco), supplemented with 10% newborn calf serum (Gibco). The doubling times for HEp-2 and 7T cells were 22 h and 26 h, respectively. Curcumin (Sigma, St. Louis, MO) was prepared in dimethylsulfoxide (DMSO) as 50 mM stock solution and stored at -20ºC for no longer than two months. After overnight incubation, cells were treated with curcumin in the dark (due to its photosensitivity) and diluted in culture medium (final concentration of DMSO being lower than 0.08%). After the treatment both adherent and floating cells were collected (adherent by tripsinization) centrifuged, counted and used in most of experiments, except for those in which the ROS induction was measured. In these experiments the cells were treated with curcumin in suspension.
Cytotoxicity assay
The sensitivity of cells to curcumin was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma) assay (Mickisch et al., 1990) . Briefly, 2.500
HEp-2 cells and 3.500 7T cells were seeded in 180 µl medium in quadruplicate in 96-well 5 5 tissue culture plates and following overnight incubation treated with curcumin. After 72 h MTT was added and the absorbance of the formazan product was measured on a microplate reader (Awareness Technology Inc, Palm City, USA) at 600 nm. To examine the influence of ROS induction on survival of curcumin treated cells, they were pretreated for 1 h with 10 mM N-acetyl-L-cysteine (NAC; Sigma) and than co-treated with curcumin for additional 72 h.
Survival of cells treated with both NAC and curcumin was calculated according to survival of cells treated only with NAC (with approximately 100% survival for both HEp-2 and 7T cells).
In addition, cells were pretreated with 22.2 µg/ml L-buthionine-sulfoximine (BSO; Sigma) for 24 h and co-treated with curcumin for the next 48 h. Survival of cells treated with both BSO and curcumin was calculated according to survival of cells treated with BSO only (with the survival of more than 92% for both, HEp-2 and 7T cells).
Because the cytotoxic potency (as well as the intracellular accumulation) of a highly lipophilic curcumin in vitro depends on the composition of the in vitro system, i.e. the relation between cell number (volume) and medium volume and the binding protein and lipid content of the medium, we have done all our experiments in the medium supplemented with 10 % of newborn calf serum. In addition, we have examined the influence of cell number and the medium volume on the cytotoxicity of curcumin. As shown in Fig. S1 , the alteration in cell number and in the medium volume that we used in our experiments, did not influence the cytotoxicity of curcumin. In addition, in order to have the same seeding density at the time of the treatment, we always kept the same ratio between the cell number and surface of the dish that we used.
Accumulation of curcumin
HEp-2 (4x10 5 /10 ml medium) and 7T cells (6x10 5 /10 ml medium) were seeded in 10 cm Petri dishes and after overnight incubation treated with curcumin for different time periods, collected, washed twice with cold PBS and held on ice until analysis. Due to the fact that curcumin exhibits a green fluorescent signal (Khopde et al., 2000; Wang et al., 2006) , cells were analyzed using the FL1 channel of a FACSCalibur flow cytometer (Becton Dickinson; Franklin Lakes, NJ) equipped with laser emitting at 488 nm wavelength.
Fluorescence emission (above 530 nm) from 10 000 cells was collected and analyzed with BD CellQuest Pro software (BD Biosciences, San Jose, CA).
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ROS measurement
The intracellular accumulation of ROS was determined by flow cytometry using the 
DNA damage assay
HEp-2 (1.2 x 10 6 /12 ml medium) and 7T (1.7 x 10 6 /12 ml medium) cells were seeded in 10 cm Petri dishes and following overnight incubation treated with curcumin for 1 h, collected, washed with PBS and resuspended in ice-cold culture medium (2 × 10 5 cells/100 µl). Five microliters of suspension were mixed with 100 µl of 0.5% Low Melting Point agarose (Sigma) and analyzed by the alkaline comet assay (Singh et al., 1988) . The formation of oxidized purines was determined using the formamidopyrimidine glycoslyase (Fpg)
FLARE™ assay kit (Trevigen Inc, Gaithersburg, MD) with minor modifications (Gajski et al., 2008) . Slides were analyzed at 250x magnification using an epifluorescent microscope (Zeiss, Göttingen, DE) connected trough a camera to an image-analysis system (Comet Assay II; Perceptive Instruments Ltd., Haverhill, Suffolk, UK). The comet parameters, tail length and tail moment, were used to measure the level of DNA damage. A total of 200 randomly captured nuclei were examined from each slide (100 nuclei from each duplicate slide) in two independent experiments.
Characteristic nuclear morphology of apoptotic cells
The nuclear morphology typical for apoptosis was determined 72 h after treatment with curcumin by epifluorescence microscopy (Axiovert 35, Opton). The cells were trypsinized, centrifuged and washed. Thereafter 10 µl of cell suspension were labeled with 4 µl of acridine orange (AO, 15 µg/ml in PBS) and 2 µl of ethidium bromide (EtBr, 50 µg/ml in PBS) and examined for typical nuclear morphology of apoptotic cells -the condensation of chromatin to compact and simple globular geometric figures. Both live and dead cells take up acridine orange. It intercalates into DNA, making it appear green, and binds to RNA, staining it red. Thus a viable cell will have bright green chromatin in its nucleus and red-orange cytoplasm. Ethidium bromide is only taken up by nonviable cells. It intercalates into DNA, making it appear orange, but binds only weakly to RNA, which may appear slightly red. Thus a dead cell will have bright orange chromatin (the ethidium overwhelms the acridine) and its cytoplasm, if it has any contents remaining, will appear dark red. Cells that have undergone necrosis will have the fluorescent features of nonviable cells but will not have apoptotic nuclear morphology. Using this method, both normal or apoptotic nuclei in live cells will 8 8 fluoresce bright green. In striking contrast, apoptotic nuclei in dead cells will fluorescence bright orange. Fluorescence was detected through the BP 450-490, FT 510, LP 520 filter. The images were taken with the camera Pixera Pro150ES.
Annexin V-FITC/PI assay
The appearance of phosphatidylserine (PS) on the extracellular side of membrane, as a marker of apoptosis, was evaluated with Annexin V-FITC/PI method as described previously (Jakopec et al., 2006) . The percentages of three cell death categories were determined:
apoptotic (AV+, PI-), and secondary necrotic or necrotic (AV+, PI+) and live cells (AV-, PI).
Annexin V-FITC was obtained from BD Pharmingen (BD Biosciences, San Jose, CA). 
Western blot
Cells
Determination of fatty acid methyl esters
HEp-2 and 7T cells were grown in 75 cm 2 flasks for 48 h until they reached 80%
confluence. Thereafter, 1.5 × 10 7 cells were collected by trypsinization, washed with 0.9% NaCl and lyzed in 100 µl of dH 2 O. Total lipids were extracted from lysate with a mixture of isopropanol/chlorophorm (1,5:1 v/v) (Rose and Oklander, 1965) . The results were collected and analyzed using Peak Simple 3D, Version 2.97 (SRI Inc., Torrance, CA).
Statistical analysis
Data were analyzed by unpaired Student's t-test and expressed as means ± standard deviation. Results of the comet assay parameters are presented as means ± standard error, and were evaluated using Statistica 5.0 program package (StaSoft, Tulsa, OK). In order to normalize the distribution and equalize the variances of the comet assay data, a logarithmic transformation was applied. Multiple comparisons between groups were done by means of ANOVA on log-transformed data. Post-hoc analyses of differences were done by the Newman-Keuls test. Data were considered statistically significant at p-value of < 0.05.
Results
Sensitivity of HEp-2 and 7T cell line to curcumin
Human laryngeal carcinoma HEp-2 cells and the carboplatin resistant 7T subline were exposed to various concentrations of curcumin, and their survival was determined 72 h later.
Curcumin inhibited the growth of both cell lines in a dose-dependent manner, but carboplatin resistant 7T cells were cross resistant to this natural drug (Fig. 1) . From obtained survival curve we selected two concentrations of curcumin, equimolar and equitoxic, for further studies. At equimolar concentration of 25 µM curcumin the differences in cell survival between HEp-2 and 7T cells were most pronounced: 30% percent of HEp-2 cells survived this curcumin concentration, as compared to 65% of 7T cells. To reach the same survival level, 7T cells had to be treated with 40 µM curcumin and this concentration was marked as equitoxic concentration.
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Curcumin accumulation in HEp-2 and 7T cells
We quantified curcumin accumulation by flow cytometry since curcumin has the ability to fluoresce in the green band. Curcumin fluorescence is weak in aqueous solutions (Khopde et al., 2000) , but in hydrophobic micelles it is enhanced by nearly 55 times (Wang et al., 2006) . Since curcumin is a lipophilic compound and accumulates mainly in the membranes (Kunwar et al., 2008) , its accumulation in hydrophobic parts of membranes probably explains significant fluorescence that was detected by flow cytometry. The presence of extracellularly bound curcumin is probably not detected due to its weak florescence in aqueous solutions.
Since 50% of curcumin degrades in cell culture medium after 8 h of incubation ( 
Curcumin induced ROS formation in HEp-2 and 7T cells
Numerous literature data suggest that ROS induction is one of the first effects of curcumin treatment and it is involved in its cytotoxicity (Chen et al., 2010; Fujisawa S, 2004; Khar et al., 2001) . Therefore, we examined and compared ROS induction in HEp (Fig. 3B) . If the cells were pretreated with BSO, again the differences in cell survival were more expressed in HEp-2 cells (Fig. 3C) . However, the influence on cell survival of both, NAC and BSO was similar on HEp-2 and 7T cells when equitoxic concentration of curcumin was used ( Fig. 3B and 3C HEp-2 cells than in 7T cells, but at equitoxic concentration (40 µM) the amount of MDA was almost the same (Fig. 4A ).
Oxidative damage at DNA level was detected by the FPG-modified comet assay. The results showed that in both cell lines there was significant increase in DNA strand breaks (Fig.   4B , see buffer control), but only in HEp-2 cell line a small increase in oxidative DNA damage was detected at both concentrations of curcumin used or just for equitoxic dose by the parameter of tail moment (Fig. 4B) . The presence of DNA strand breaks was also confirmed by standard alkaline comet assay (Fig. 4C) , which again showed correlation with cytotoxicity of curcumin and equitoxic doses showed the similar amount of DNA strand breaks.
Curcumin induced apoptosis in HEp-2 and 7T cells
In order to see the downstream effects of curcumin induced ROS formation, lipid and DNA damage in HEp-2 and 7T cells, we applied different techniques. The results presented in Fig. 5A show typical nuclear apoptotic characteristics (condensation of chromatin to compact and simple globular geometric figures) in HEp-2 and 7T cells after the treatment with curcumin. Further, phosphatidylserine was exposed on outer side of membrane (Fig. 5B) , PARP was cleaved and caspase-3 activated (Fig. 5C ). All these results indicate that curcumin treatment induced apoptotic cell death in HEp-2 and 7T cells. At equimolar concentration of curcumin, less apoptotic cells was found in 7T cells ( Fig. 5A and 5B); this was confirmed by lack of cleavage of PARP and procaspase-3 (Fig. 5C) . However, at equitoxic concentration apoptosis induction was similar in both cell lines ( Fig. 5B and 5C ).
Curcumin induced Hsp70 expression in HEp-2 and 7T cells
It was found that curcumin induces Hsp70 expression in different cell lines and thereby protects them from apoptotic cell death (Khar et al., 2001 ). Therefore we examined the induction of Hsp70 following the treatment with curcumin. As shown in Fig. 5D , at equimolar 13 13 concentration of curcumin induction of Hsp70 expression was lower in 7T cells, as compared to HEp-2 cells, but at equitoxic concentration the induction was similar. Thus it can be concluded that Hsp70 expression is proportional to the curcumin induced stress detected in both cell lines.
Fatty acid composition of HEp-2 and 7T cell membranes
Curcumin is a lipophilic compound and accumulates mainly in the membranes. To explain the reduced accumulation of curcumin in 7T cells, we decided to explore membrane fatty acid composition. The results of gas chromatography presented in Fig. 6 show that there was no difference in fatty acid composition in 7T subline compared to HEp-2 cells.
Discussion
In order to increase the effectiveness of cancer treatment, the interest has been recently focused to the drugs that have been used in traditional medicine (Chattopadhyay et al., 2004) , like curcumin. The observed anti-tumor effects of this natural compound encouraged extensive efforts to establish its usefulness in cancer prevention and cancer treatment.
Curcumin could be an excellent candidate to target a multifactorial disease like cancer because of its broad range of activities, based on its ability to affect multiple intracellular targets (Kunnumakkara et al., 2008; Lopez-Lazaro, 2008; Teiten et al., 2010) .
A particular problem in classic chemotherapy is the drug resistance of tumor cells. The drugs that could be efficient against chemoresistant cells could be of great importance in enhancing effectiveness of cancer treatment. There are some data in the literature that verified anticancer properties of curcumin in drug resistant cells (Labbozzetta et al., 2009; Lu et al., 2012; Sung et al., 2009; Weir et al., 2007) . However, these data should be more abundant in order to make more general conclusions about curcumin's activity against drug resistant cells.
To our knowledge, such data are missing for laryngeal carcinoma cells. Therefore our study was focused on carboplatin resistant human laryngeal carcinoma cells. Our aim was to explore their sensitivity to curcumin, and if this sensitivity is altered, to determine the molecular mechanism that are responsible for it. We found that carboplatin resistant 7T cells are also cross resistant to curcumin.
Curcumin is a lipophilic compound, unstable in aqueous solutions (Wang et al., 1997) ,
In the study on rat thymocytes it was shown that such properties enable this molecule to easily 14 14 enter the cell and localize in the membrane regions like: plasma membrane, membranes of endoplasmic reticulum and nuclear envelope (Jaruga et al., 1998) . In one of the recent papers it was found that, except for membrane localization, minor nuclear localization occurred in mouse spleen lymphocytes, mouse fibroblast (NIH3T3), T cell lymphoma of murine origin (EL4) and breast cancer cell line of human origin (MCF7) (Kunwar et al., 2008) . Cytotoxicity study on these cell lines indicated that curcumin toxicity in one individual cell line increased with its increased accumulation, but general correlation between accumulation and toxicity was not found. To see if there is some correlation between accumulation and cytotoxicity in our model system, curcumin accumulation was explored based on quantifying the fluorescence of intracellular curcumin. Our results showed that 7T cells accumulate less curcumin compared to HEp-2 cells. Since intracellular curcumin accumulation was similar in both cell lines at equitoxic doses, we supposed that reduced cytotoxicity of curcumin applied in equimolar doses could be due to lower intracellular accumulation of curcumin in 7T cells.
To confirm our hypothesis, we explored the downstream events of curcumin accumulation.
There are numerous reports about the production of reactive oxygen species (ROS) as one of the first steps in curcumin cytotoxicity to different tumor cell lines (Atsumi et al., 2005; Chen et al., 2010; Fujisawa S, 2004; Hail, 2008; Kang et al., 2005) . We also detected ROS formation quite early after curcumin was added and found more ROS in parental HEp-2 cells. ROS presence and its role in cytotoxicity were also confirmed for both HEp-2 and 7T cell line after longer period of incubation with curcumin combined with NAC and BSO treatment. Since both of them influence cellular GSH level, we checked basal GSH concentration in both cell lines and found that it was the same (data not shown). Although ROS can cause serious damage to lipids, proteins, and DNA (Halliwell and Gutteridge, 1999) . Since we detected an early alteration in ROS formation following the treatment with curcumin, we also measured early ROS induced damage on lipids and DNA.
Our results showed that curcumin treatment in HEp-2 and 7T cell line induced lipid peroxidation and DNA damage after only one hour of treatment. The level of lipid peroxidation correlated with cytotoxicity of curcumin. Similar correlation between curcumin induced ROS formation, lipid damage and cytotoxicity was observed on primary gingivial fibroblast (HGF) and human submandibular adenocarcinoma cells (HSG) (Atsumi et al., 2005) .
The induction of DNA damage that we observed in HEp-2 and 7T cells following the treatment with curcumin is in agreement with those previously reported, despite differences in the type of cells and experimental conditions used (Cao et al., 2006; Huang et al., 2011; Jiang et al., 2010; Lin et al., 2008; Lopez-Lazaro et al., 2007; Su et al., 2006; Urbina-Cano et al., 2006 ). Although we have expected that more oxidative DNA damage (like oxidized purines)
would appear in HEp-2 and 7T cells because of ROS induction, strand breaks were predominant and correlated with cytotoxicity. However, minor oxidative DNA damage was found only in HEp-2 cells, and this could be the result of enhanced early ROS induction found in these cells. Presence of DNA strand breaks after curcumin treatment could be explained by the work of Jiang et al (2010) . They showed the role of mismatch repair system in curcumin induction of DNA double strand breaks at the place of mutagenic adduct 8-oxo guanine. Also, curcumin has been shown to induce topoisomerase I-and II-DNA complexes in K562 leukemia cells (Lopez-Lazaro et al., 2007) . They were inhibited by the antioxidants like NAC, suggesting that their formation was mediated by ROS. Cellular processing converts these complexes into permanent DNA strand breaks that trigger cell death (Binaschi et al., 1995; Champoux, 2001; Onda et al., 2008; Sordet et al., 2003) .
There are numerous reports about ROS involvement in curcumin induced apoptosis in the literature (Atsumi et al., 2005; Chen et al., 2010; Fujisawa S, 2004; Hail, 2008; Kang et al., 2005) . Apoptosis inhibition was found to be one of the causes of resistance to curcumin in some cell lines (Karunagaran et al., 2005) . Therefore, we decided to explore curcumin induced cell death in HEp-2 and 7T cells. The results of different methods showed that curcumin treatment induced apoptotic cell death in both cell lines which was in correlation with curcumin cytotoxicity. When intracellular accumulation of curcumin, ROS induction, 16 16 and the level of lipid and DNA damage were similar in HEp-2 and 7T cells (as observed for equitoxic doses of curcumin), the downstream effect, i. e. apoptosis induction, was also similar. Therefore, we excluded the alterations in apoptosis induction as possible cause of curcumin resistance in 7T cell line. On the contrary, several reports showed that inhibition of apoptosis was the cause of curcumin resistance. For example, a number of published data reported that overexpression of antiapoptotic proteins, like Bcl-2, Bcl-XL and Smac protected cancer cells from curcumin treatment (Karunagaran et al., 2005) . Therefore we examined the expression of antiapoptotic Bcl-2 protein. We determined its expression until the 24 h after the treatment when apoptosis was detected by PARP cleavage (Fig. S3 ). There were no increase in Bcl-2 expression neither in HEp-2 nor 7T cell line during that time period (Fig.   S2 ). This further supported our conclusion that altered expression of antiapoptotic proteins is not the cause of curcumin resistance in 7T cell line.
Hsp70 is usually expressed upon different stress stimuli (Silver and Noble, 2011) .
Curcumin resistant cell lines established from lung, kidney, prostate, cervix, CNS malignancies and melanomas showed higher production of antiapoptotic protein Hsp70 upon ROS induction and thereby protecting them from apoptotic cell death (Khar et al., 2001 ).
Also, human colon cancer cells treated with curcumin were protected from apoptotic cell death due to Hsp70 induction upon heat treatment (Rashmi et al., 2003) or ectopic Hsp70 overexpression (Rashmi et al., 2004) . Hsp70 silencing enhanced curcumin induced apoptosis in those cancer cells (Rashmi et al., 2004) . Therefore, we examined the expression of Hsp70 Changes in drug accumulation can play an important role in drug sensitivity and drug resistance of tumor cells (Casas et al., 2011; Fodale et al., 2011; Gottesman, 2002) . This can be achieved through altered properties in cell membrane lipids as it was recently shown with isolated lipids from doxorubicin sensitive (MCF-7) and resistant (MCF-7/ADR) breast cancer cells (Peetla et al., 2010) . Also, fatty acid analysis of vincristine sensitive KB-3-1 and vincristine resistant KB-ChR-8-5 cells showed that the resistant cell line had lower amounts of unsaturated fatty acids (Das et al., 1998) . In line with that, when membrane phospholipids 17 of L1210 murine leukemia cells were enriched with fatty acids of variable saturation degrees the accumulation of adriamycin directly correlated with the degree of fatty acid membrane saturation (Burns and North, 1986) .
In order to determine the cause of reduced curcumin accumulation in 7T cells, accompanied by its lower cytotoxicity in these cells, we explored some characteristics of cell membranes in HEp-2 and 7T cell line, since curcumin is a lipophilic compound and accumulates mainly in the membranes. Our results showed that there was no difference in membrane fatty acid composition between 7T and HEp-2 cells. We must point out that in our experiments we extracted lipids from whole cells, because curcumin can accumulate not only in plasma membrane, but also in membranes of endoplasmic reticulum and nuclear envelope (Jaruga et al., 1998) . Therefore, we can not exclude some differences in fatty acid composition between membranes of different cell compartments. An additional cause of changed intracellular curcumin accumulation could be the altered activity of ATP hydrolyzing cellular transporters, a superfamily of transmembrane proteins, that export a wide variety of natural and synthetic compounds from the cells (Deeley et al., 2006) . One of them, the ATPbinding cassette transporter ABCA1, is involved in cholesterol efflux, but can also influence the sensitivity to curcumin, as shown recently (Bachmeier et al., 2009) . To further explore the molecular mechanisms of altered curcumin accumulation in drug resistant 7T cells, our future research will be focused on cell membranes and membrane transporters. 
